| Name | h-ile-ile-gly-leu-met-oh |
|---|---|
| Synonyms |
IIGLM
Isoleucinyl-isoleucinyl-glycinyl-leucinyl-methionine amyloid B-protein fragment 31-35*acetate ILE-ILE-GLY-LEU-MET Amyloid β-Protein (31-35) β-Amyloid (31-35) |
| Description | β-Amyloid (31-35) is the shortest sequence of native Amyloid-β peptide that retains neurotoxic activity. |
|---|---|
| Related Catalog | |
| In Vitro | β-Amyloid (31-35) is a functional cytotoxic domain of Aβ peptide. β-Amyloid (31-35) increases the phosphorylation of biotinylated Aβ(1-40), enhances CDK-1 activity, and also inhibits binding of Aβ to cyclin B1. β-Amyloid (31-35) is cytotoxic, and such an effect can be inhibited by olomoucine in differentiated human teratocarcinoma cell line, Ntera 2/cl-D1 (NT-2) neurons[1]. β-Amyloid (31-35) shows cytotoxic effect on cerebellar granule cells (CGC). β-Amyloid (31-35) also increases caspase-3 activity in a time-dependent manner (4-24 h) at 40 μM[2]. |
| References |
| Density | 1.137 g/cm3 |
|---|---|
| Boiling Point | 866.382ºC at 760 mmHg |
| Molecular Formula | C25H47N5O6S |
| Molecular Weight | 545.73600 |
| Exact Mass | 545.32500 |
| PSA | 205.02000 |
| LogP | 3.12420 |
| Storage condition | −20°C |